CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-03 | Yoo Stephen Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2018-01-03 | Danos Olivier Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +41,250 | 41,250 | ||
| 2018-01-03 | Vasista Vittal Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2018-01-03 | Mills Kenneth T. President and CEO | Grant or award · Stock Option (Right to Buy) | +163,500 | 163,500 | ||
| 2017-12-29 | Christmas Patrick J. SVP, General Counsel | Grant or award | +486 | $17.43 | $8K | 1,141 |
| 2017-12-22 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +30,000 | $22.00 | $660K | 69,500 |
| 2017-12-22 | Simpson Curran SVP, Technical Operations | Sale | −30,000 | $33.03 | $991K | 39,500 |
| 2017-12-22 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −30,000 | 180,500 | ||
| 2017-12-20 | Mills Kenneth T. President and CEO | Sale | −10,000 | $31.75 | $318K | 108,530 |
| 2017-12-19 | Vasista Vittal Chief Financial Officer | Sale | −4,994 | $30.00 | $150K | 82,283 |
| 2017-12-18 | Vasista Vittal Chief Financial Officer | Sale | −6 | $30.00 | $180 | 87,277 |
| 2017-12-07 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +1,890 | $13.09 | $25K | 41,390 |
| 2017-12-07 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +20,000 | $22.00 | $440K | 61,390 |
| 2017-12-07 | Simpson Curran SVP, Technical Operations | Sale | −21,890 | $30.04 | $658K | 39,500 |
| 2017-12-07 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,890 | 6,000 | ||
| 2017-12-07 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 210,500 | ||
| 2017-12-04 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +110 | $13.09 | $1K | 39,610 |
| 2017-12-04 | Simpson Curran SVP, Technical Operations | Sale | −110 | $30.00 | $3K | 39,500 |
| 2017-12-04 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −110 | 7,890 | ||
| 2017-11-27 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +2,000 | $13.09 | $26K | 41,500 |
Page 44 of 56 · 1,104 trades